Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-09-10, Stock:ABBV, The news for the past five days is as follows:
2021-09-02: NEWS1: AbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown..NEWS2: 7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In.NEWS3: AbbVie (ABBV) Stock Down as FDA Issues New Warning for Rinvoq.NEWS4: FDA Orders Warnings on Pfizer, Lilly, AbbVie JAK Drug Labels.NEWS5: FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know.NEWS6: 3 Biotech Stocks That Are Too Cheap to Ignore.NEWS7: Stall Speed? Jobs Gut Punch, Taiwan Worries, Mu Variant, Trading AbbVie.
2021-09-03: NEWS1: Pharma Stock Roundup: New Warning Order by FDA for JAK Drugs, & Pipeline Updates.NEWS2: Are Investors Undervaluing AbbVie Inc. (NYSE:ABBV) By 48%?.
2021-09-07: NEWS1: Top Analyst Reports for Facebook, AbbVie & 3M.
2021-09-08: NEWS1: AbbVie (ABBV) Gains As Market Dips: What You Should Know.NEWS2: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS3: AbbVie to Present Data From Its Migraine Portfolio at the 2021 International Headache Congress.
2021-09-09: NEWS1: Could This Label Expansion Be a Blockbuster for AbbVie's Shareholders?.NEWS2: AbbVie to Present at the Morgan Stanley Healthcare Conference.NEWS3: Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell non-Hodgkin’s Lymphoma (B-NHL) Published in The Lancet.

Answer: Decrease